Logo image of CPRT

COPART INC (CPRT) Stock Fundamental Analysis

NASDAQ:CPRT - Nasdaq - US2172041061 - Common Stock - Currency: USD

60.81  -0.28 (-0.46%)

Fundamental Rating

7

CPRT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 83 industry peers in the Commercial Services & Supplies industry. Both the health and profitability get an excellent rating, making CPRT a very profitable company, without any liquidiy or solvency issues. CPRT is quite expensive at the moment. It does show a decent growth rate. These ratings could make CPRT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year CPRT was profitable.
In the past year CPRT had a positive cash flow from operations.
Each year in the past 5 years CPRT has been profitable.
CPRT had a positive operating cash flow in each of the past 5 years.
CPRT Yearly Net Income VS EBIT VS OCF VS FCFCPRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

With an excellent Return On Assets value of 15.83%, CPRT belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
With a decent Return On Equity value of 17.52%, CPRT is doing good in the industry, outperforming 79.52% of the companies in the same industry.
CPRT has a better Return On Invested Capital (15.14%) than 87.95% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPRT is significantly above the industry average of 10.89%.
The last Return On Invested Capital (15.14%) for CPRT is well below the 3 year average (19.14%), which needs to be investigated, but indicates that CPRT had better years and this may not be a problem.
Industry RankSector Rank
ROA 15.83%
ROE 17.52%
ROIC 15.14%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.79%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
CPRT Yearly ROA, ROE, ROICCPRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of CPRT (32.27%) is better than 96.39% of its industry peers.
CPRT's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 36.16%, CPRT belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
In the last couple of years the Operating Margin of CPRT has remained more or less at the same level.
CPRT has a better Gross Margin (44.75%) than 77.11% of its industry peers.
In the last couple of years the Gross Margin of CPRT has remained more or less at the same level.
Industry RankSector Rank
OM 36.16%
PM (TTM) 32.27%
GM 44.75%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
CPRT Yearly Profit, Operating, Gross MarginsCPRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CPRT is creating value.
CPRT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CPRT has been increased compared to 5 years ago.
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPRT Yearly Shares OutstandingCPRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPRT Yearly Total Debt VS Total AssetsCPRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPRT has an Altman-Z score of 42.72. This indicates that CPRT is financially healthy and has little risk of bankruptcy at the moment.
CPRT has a Altman-Z score of 42.72. This is amongst the best in the industry. CPRT outperforms 100.00% of its industry peers.
CPRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 42.72
ROIC/WACC1.66
WACC9.12%
CPRT Yearly LT Debt VS Equity VS FCFCPRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

CPRT has a Current Ratio of 7.89. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
CPRT's Current ratio of 7.89 is amongst the best of the industry. CPRT outperforms 96.39% of its industry peers.
CPRT has a Quick Ratio of 7.79. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
CPRT's Quick ratio of 7.79 is amongst the best of the industry. CPRT outperforms 96.39% of its industry peers.
Industry RankSector Rank
Current Ratio 7.89
Quick Ratio 7.79
CPRT Yearly Current Assets VS Current LiabilitesCPRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.76% over the past year.
Measured over the past 5 years, CPRT shows a small growth in Earnings Per Share. The EPS has been growing by 4.32% on average per year.
The Revenue has grown by 11.00% in the past year. This is quite good.
Measured over the past years, CPRT shows a quite strong growth in Revenue. The Revenue has been growing by 15.72% on average per year.
EPS 1Y (TTM)8.76%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%21.21%
Revenue 1Y (TTM)11%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%14.03%

3.2 Future

Based on estimates for the next years, CPRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.98% on average per year.
CPRT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.53% yearly.
EPS Next Y15.67%
EPS Next 2Y14.47%
EPS Next 3Y14.48%
EPS Next 5Y11.98%
Revenue Next Year10.75%
Revenue Next 2Y9.99%
Revenue Next 3Y11.01%
Revenue Next 5Y11.53%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CPRT Yearly Revenue VS EstimatesCPRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
CPRT Yearly EPS VS EstimatesCPRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.81 indicates a quite expensive valuation of CPRT.
The rest of the industry has a similar Price/Earnings ratio as CPRT.
The average S&P500 Price/Earnings ratio is at 26.03. CPRT is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 33.39, CPRT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CPRT is on the same level as its industry peers.
CPRT is valuated expensively when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 40.81
Fwd PE 33.39
CPRT Price Earnings VS Forward Price EarningsCPRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

63.86% of the companies in the same industry are cheaper than CPRT, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as CPRT.
Industry RankSector Rank
P/FCF 57.78
EV/EBITDA 29.76
CPRT Per share dataCPRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPRT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CPRT may justify a higher PE ratio.
CPRT's earnings are expected to grow with 14.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.6
PEG (5Y)9.44
EPS Next 2Y14.47%
EPS Next 3Y14.48%

More info and screens

0

5. Dividend

5.1 Amount

CPRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COPART INC

NASDAQ:CPRT (5/22/2025, 9:41:40 AM)

60.81

-0.28 (-0.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-22 2025-05-22/amc
Inst Owners84.69%
Inst Owner Change2.19%
Ins Owners8.68%
Ins Owner Change0%
Market Cap58.75B
Analysts77.65
Price Target63.84 (4.98%)
Short Float %1.99%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.36%
Min EPS beat(2)-0.98%
Max EPS beat(2)5.7%
EPS beat(4)1
Avg EPS beat(4)-1.76%
Min EPS beat(4)-10.92%
Max EPS beat(4)5.7%
EPS beat(8)4
Avg EPS beat(8)0.24%
EPS beat(12)7
Avg EPS beat(12)-0.31%
EPS beat(16)11
Avg EPS beat(16)2.79%
Revenue beat(2)2
Avg Revenue beat(2)1.51%
Min Revenue beat(2)0.81%
Max Revenue beat(2)2.21%
Revenue beat(4)3
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)2.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.13%
Revenue beat(16)11
Avg Revenue beat(16)2.1%
PT rev (1m)0.14%
PT rev (3m)1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.79%
EPS NY rev (1m)0%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 40.81
Fwd PE 33.39
P/S 13.04
P/FCF 57.78
P/OCF 36.81
P/B 7.08
P/tB 7.61
EV/EBITDA 29.76
EPS(TTM)1.49
EY2.45%
EPS(NY)1.82
Fwd EY3%
FCF(TTM)1.05
FCFY1.73%
OCF(TTM)1.65
OCFY2.72%
SpS4.66
BVpS8.59
TBVpS7.99
PEG (NY)2.6
PEG (5Y)9.44
Profitability
Industry RankSector Rank
ROA 15.83%
ROE 17.52%
ROCE 19.04%
ROIC 15.14%
ROICexc 27.23%
ROICexgc 30.99%
OM 36.16%
PM (TTM) 32.27%
GM 44.75%
FCFM 22.56%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.79%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
ROICexc(3y)30.14%
ROICexc(5y)28.88%
ROICexgc(3y)50.08%
ROICexgc(5y)42.59%
ROCE(3y)24.07%
ROCE(5y)25.2%
ROICexcg growth 3Y-0.59%
ROICexcg growth 5Y-0.42%
ROICexc growth 3Y-0.76%
ROICexc growth 5Y0.83%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 274.59%
Cap/Sales 12.85%
Interest Coverage 661.79
Cash Conversion 86.72%
Profit Quality 69.92%
Current Ratio 7.89
Quick Ratio 7.79
Altman-Z 42.72
F-Score5
WACC9.12%
ROIC/WACC1.66
Cap/Depr(3y)278.53%
Cap/Depr(5y)355.91%
Cap/Sales(3y)11.68%
Cap/Sales(5y)15.82%
Profit Quality(3y)72%
Profit Quality(5y)63.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.76%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%21.21%
EPS Next Y15.67%
EPS Next 2Y14.47%
EPS Next 3Y14.48%
EPS Next 5Y11.98%
Revenue 1Y (TTM)11%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%14.03%
Revenue Next Year10.75%
Revenue Next 2Y9.99%
Revenue Next 3Y11.01%
Revenue Next 5Y11.53%
EBIT growth 1Y2.81%
EBIT growth 3Y11.42%
EBIT growth 5Y17.02%
EBIT Next Year19.63%
EBIT Next 3Y16.44%
EBIT Next 5Y13.88%
FCF growth 1Y28.39%
FCF growth 3Y22.13%
FCF growth 5Y28.66%
OCF growth 1Y29.75%
OCF growth 3Y14.12%
OCF growth 5Y17.89%